Amicus Therapeutics Inc (FOLD) – Strategy, SWOT and Corporate Finance Report

Amicus Therapeutics Inc (FOLD) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company, which focuses on the research, development and commercialization of small molecule drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. It's lead product, migalastat HCl, a small molecule, is indicated for the treatment of Fabry disease. The other products in the pipeline include ATB200/AT2221 for the treatment of Pompe disease, Fabry disease, and other lysosomal storage disorders; migalastat for other conditions; and enzyme replacement therapies for other rare diseases. The company has presence in the US, the UK, Ireland, France, the Netherlands, Germany, Spain, Italy and Japan. Amicus Therapeutics is headquartered in Philadelphia, Pennsylvania, the US.

Scope

• Detailed information on Amicus Therapeutics Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Amicus Therapeutics Inc in the form of a SWOT analysis

• An in-depth view of the business model of Amicus Therapeutics Inc including a breakdown and examination of key business segments

• News about Amicus Therapeutics Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Amicus Therapeutics Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Amicus Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Dewpoint Therapeutics Inc

RegeneRx Biopharmaceuticals Inc

Shire Pharmaceuticals International UC

Fibrocell Science Inc

Dewpoint Therapeutics Inc

RegeneRx Biopharmaceuticals Inc

Shire Pharmaceuticals International UC

BioMarin Pharmaceutical Inc

Sanofi Genzyme US

Astellas Gene Therapies

BioMarin Pharmaceutical Inc

Astellas Gene Therapies

Fibrocell Science Inc

Sanofi Genzyme US

Table of Contents